Discussion about this post

User's avatar
Jen's avatar

Prof G, you say that you can't sanction the off-label prescribing of metformin, but metformin is part of the OCTOPUS/PLATYPUS trial. Are you saying it's not safe?

Expand full comment
Annonie Mouse's avatar

Just to mention that this patient is not eligible for simvastatin trial MS-STAT2 as requirements include:

1. diagnosis of SPMS min 2 years

2. no dmts (apart from siponimod)

In any case, recruitment closes tomorrow 31 August (web enquiries already taken down so would have to make quick contact direct with centre)

UK patients only.

Expand full comment
5 more comments...

No posts